Tali Digital Ltd Overview
| Attribute | Detail | Source |
|---|---|---|
| Legal name | TALi Digital Limited | FY26 Annual Report |
| Styling | Company styles itself "TALi Digital" (lower-case "i") | Company announcements |
| Former names | Avexa Limited (to December 2016); Novita Healthcare Limited (December 2016 to 30 December 2019) | MarketBeat, Biotech Daily (secondary); ASX Notice 0021.20.12 |
| Former ASX codes | NHL (Novita Healthcare) | ASX Notice 0021.20.12 |
| Incorporation date | 7 April 2004 | FY26 Annual Report ("no dividend has been paid… since its incorporation on 7 April 2004") |
| Jurisdiction | Australia (Corporations Act 2001); tax-consolidated group with Australian subsidiaries | FY25/FY26 Annual Reports |
| Registered office and principal place of business | Suite 1.01, 117 Camberwell Road, Hawthorn East, VIC 3123, Australia | FY26 Annual Report |
| Prior office | Suite 201, 697 Burke Road, Camberwell, VIC 3124 (to FY2025) | FY25 Annual Report |
| Telephone | 1300 082 013 | Company announcements |
| Investor email | investors@talidigital.com | Datasphere announcement, 24 Aug 2026 |
| Exchange and ticker | Australian Securities Exchange, TD1 | FY26 Annual Report |
| Secondary quotation | Stuttgart, UV7 (aggregator listing; no evidence of a sponsored secondary listing) | TipRanks (aggregator) |
| ISIN | AU0000074221 | ASX Notice 0021.20.12 |
| CUSIP | Not applicable / not publicly disclosed | — |
| Fiscal year end | 30 June | FY26 Annual Report |
| Auditor | RSM Australia Partners, Melbourne (lead partner A L Whittingham); unmodified opinion FY25 and FY26 | FY26 Annual Report |
| Share registry | Automic Registry Services, Sydney | FY26 Annual Report |
| Solicitor | Baker McKenzie, Melbourne (as listed in FY25 directory) | FY25 Annual Report |
| Lead manager (Aug 2026 raise) | 62 Capital Pty Ltd (6% fee on placement) | Datasphere announcement |
| Company secretary / outsourced CFO | Tim Luscombe (Bio101), appointed 5 December 2022 | FY26 Annual Report |
| Subsidiaries | TALi Health Pty Ltd (100%); YCDI Education Australia Pty Ltd (100%, from 12 June 2025); Datasphere Analytics Pty Ltd (100%, from completion on or about 29 Sep–1 Oct 2026) | FY26 Annual Report; Appendix 2A filings |
| Operating segments | One segment (since 1 July 2020) | FY25 Annual Report, note 4(j) |
The identification details supplied (Tali Digital Ltd, ASX, TD1.AX, ISIN AU0000074221, talidigital.com, Australia) match the current listed entity. No re-listing or further name change has occurred since December 2019. The entity profiled is TALi Digital Limited (ABN 53 108 150 750; ACN 108 150 750), ASX code TD1, website www.talidigital.com.
| Metric | Value | Source and comment |
|---|---|---|
| Employees (aggregator) | 13 | Morningstar profile. Not confirmed in filings; likely stale. |
| Employee benefits and personnel expense FY2026 (AUD) | 452,465 | FY26 Annual Report |
| Employee benefits and personnel expense FY2025 (AUD) | 197,268 | FY25 Annual Report |
| Employee benefits and personnel expense FY2024 (AUD) | 344,994 | FY25 Annual Report (comparative) |
| YCDI acquisition | "No employees are included in the transaction" | FY25 Annual Report |
| Headcount, 3-year trend | — | The annual reports do not state a headcount. The business relies heavily on outsourced CFO/company secretarial (Bio101), consultants and subject-matter experts. |
Market capitalisation (as at mid-October 2026)
| Input | Value | Source |
|---|---|---|
| Quoted shares after 1 Oct 2026 Tranche 2 quotation | 112,727,470 | Kalkine summary of Appendix 2A, 1 Oct 2026 |
| Datasphere consideration shares (quotation applied 1 Oct 2026) | 22,000,000 | Kalkine summary of Appendix 2A, 1 Oct 2026 |
| Implied shares on issue | approximately 134.7 million (analyst calculation; assumes the 22M consideration shares are additional to the 112.7M) | Analyst calculation |
| Recent prices | AUD 0.090 at 26 Aug 2026 release; AUD 0.078–0.10 range observed in Aug–Oct 2026 on aggregator pages | InvestSMART, StockLight (secondary) |
| 52-week range | AUD 0.04–0.15 | StockLight (secondary) |
| Estimated market capitalisation | AUD 10.8M–13.5M at AUD 0.08–0.10 per share (analyst calculation) | Analyst calculation |
The estimate below uses filed share counts and recent observed prices.
Earlier aggregator snapshots (AUD 2.1M on Simply Wall St; AUD 3–4M on InvestSMART; €2.26M on Parqet) pre-date the August–October 2026 recapitalisation and the Datasphere issue, and are superseded.
TALi Digital is an Australian micro-cap that has migrated, in three distinct phases, from failed HIV drug developer (as Avexa), to paediatric digital-health company (TALi DETECT and TALi TRAIN attention screening and training, rooted in Monash University research), to school social-emotional learning (SEL) provider after acquiring the You Can Do It! Education (YCDI!) business in June 2025. In FY2026 YCDI! generated effectively all of the group's AUD 274,898 revenue, mainly from digital school subscriptions on a CANVAS learning-management platform, physical early-years resources and royalties. In August–October 2026 the company bolted on Datasphere Analytics, an early-stage vehicle holding an option to license memristive processing-in-memory IP from Israel's Technion. The stated intent is to turn YCDI! into an AI-assisted, sovereign-data education platform. The investment case is therefore a small, real but sub-scale SEL business plus a long-dated, unproven deep-technology option, funded by a freshly raised equity base.
Company's own description (FY2026 Annual Report, paraphrased)
The FY2026 Annual Report describes TALi as a digital health company delivering diagnostic and therapeutic solutions to enhance attention and cognitive function, built on a patented platform targeting cognitive attention skills, incorporated into the ReadyAttentionGo! training modules. These are play-based programs designed to complement existing therapy, with a vision of improving childhood cognitive performance through early intervention. ReadyAttentionGo! is being considered as a component of neurodivergent learning strategies being developed for the YCDI! programs (ages 3–18). The company's broader focus is described as "technologies that can be a platform to enhance learning".
The report then describes YCDI!, acquired June 2025, as a leading Australian SEL program. Per the company, it has reached over one million students, is aligned with the ACARA national curriculum, and is recognised by Beyond Blue's Be You initiative. It provides evidence-based programs for children aged 3–18, self-paced tertiary online courses, professional development for educators and parent micro-courses, built around five skills: confidence, persistence, organisation, getting along and resilience.
The FY2026 operating review states the overarching objective for YCDI!: to build a comprehensive, AI-assisted universal platform that enhances SEL, educational outcomes and personal development. It adds that in FY2026 the company began actively seeking strategic M&A in the AI sector.
Independent characterisation
Despite the "digital health" label, TALi is today economically an Australian K-12 and early-childhood education-services business. The digital-health heritage (TALi DETECT and TRAIN) generated no meaningful revenue in FY2024–FY2025. Its intangible assets were fully impaired in FY2024 (AUD 4.19M). The product rights were tied up in the administration of distribution partner Genius Learning (Vertical 4 Pty Ltd) from March 2025. The FY2026 revenue disaggregation contains no line identifiable as TALi DETECT/TRAIN revenue.
The Datasphere acquisition adds a third, conceptually separate element: an option on a deep-technology hardware/architecture IP licence (memristive in-memory computing). It is pre-revenue, carries Technion royalty and capital-raising conditions subsequent, and is linked to the education business mainly by a sovereign-data narrative.
Business model and revenue model
| Revenue stream (FY2026) | Recognition | AUD | % of revenue | Description |
|---|---|---|---|---|
| Service revenue (subscriptions) | Over time, straight-line over subscription term | 194,094 | 70.6% | Annual digital subscriptions to YCDI! content and learning resources via CANVAS LMS |
| Sale of goods | Point in time (delivery) | 38,986 | 14.2% | YCDI! non-digital materials (puppets, activity books, travel bags, printed resources) |
| Royalties | As earned | 41,818 | 15.2% | Royalty income. The counterparty is not identified; a portion is earned in Europe. |
| Total | — | 274,898 | 100.0% | FY26 Annual Report, note 4 |
Percentages are analyst calculations.
Mix characterisation: about 71% subscription/SaaS-like, 14% product, 15% licensing/royalty. Deferred income rose from AUD 3,532 to AUD 189,499 over FY2026 (current-year additions AUD 380,061). This means FY2026 billings were materially above recognised revenue, a positive lead indicator for FY2027 recognised revenue if renewals hold.
Value-chain position
TALi is a content owner and platform operator. It owns YCDI! curriculum IP and brand. It licenses third-party LMS infrastructure (CANVAS), sources physical resources from suppliers, and sells direct to schools and educators. Partnerships extend reach (e.g., the Resilient Educator Partnership with an independent schools network in Victoria). In the legacy TALi business, the company owned patented software and outsourced product development, sales and support to Genius from August 2023. With Datasphere it would sit at the upstream IP-licensee layer of a semiconductor/computing-architecture value chain, initially as a research-funding vehicle.
Customer types and end-markets
| Customer type | Product | Evidence |
|---|---|---|
| Primary and secondary schools (government, Catholic, independent) | YCDI! subscriptions, workshops, PD | FY26 Annual Report |
| Early-childhood centres / early years | Puppets, early-years programs | FY26 Annual Report |
| Teachers and school staff (wellbeing) | Resilient Educator Partnership, 21-Day Reset, Mental Health First Aid | Announcement, 23 Jul 2026 |
| Tertiary/self-paced learners | Online courses | FY26 Annual Report |
| Parents | Micro-courses, take-home resources | FY26 Annual Report |
| International schools/distributors | Exploratory interest in Estonia, Romania, Saudi Arabia, New Zealand, Japan | FY26 Annual Report |
| Clinicians, NDIS participants (legacy) | TALi DETECT/TRAIN | Stockhead (2019); company materials |
End-markets: Australian K-12 SEL and student wellbeing; teacher wellbeing and professional learning; early-childhood education; legacy paediatric attention screening and training; prospectively secure data processing and in-memory computing.
Strategy
Stated strategic themes (FY2026 Annual Report and 2026 announcements, paraphrased)
-
Build YCDI! into a comprehensive, AI-assisted universal platform for SEL, educational outcomes and personal development across the whole school community.
-
Accelerate via strategic acquisitions, including AI technologies. FY2026 added an active AI-sector M&A search.
-
Sales growth, retention, partnerships and cross-selling, the four-pillar commercial strategy outlined in the January/February 2026 update.
-
Digital capability and impact reporting: refine CANVAS, embed outcome measurement.
-
Sovereign, secure data analytics. Datasphere is positioned to give TALi in-house ability to analyse sensitive student and staff data (attention and cognitive data, learning progress, wellbeing screening) without reliance on third-party infrastructure.
-
Replicate partnership models across states: Resilient Educator in Victoria first, with intent to replicate in other states.
-
International exploration: Estonia, Romania, Saudi Arabia, New Zealand, Japan.
Initiative register (last 24 months)
| Date | Initiative | Type | Targets / metrics disclosed | Status |
|---|---|---|---|---|
| Jun 2025 | YCDI! acquisition | M&A / new business | AUD 1.34M cash | Completed; fully impaired FY2026 |
| Jun–Jul 2025 | Recapitalisation (placement plus entitlement) | Capital | AUD 0.8M plus AUD 0.13M | Completed |
| FY2026 | YCDI! migration to CANVAS LMS; flexible subscription tiers; onboarding | Platform investment | — | Completed by Feb 2026 |
| FY2026 | New early-years puppets, activity book, travel bag | Product | — | Launched |
| FY2026 | "I am THRIVING" podcast; Tuesday Thrive campaign; Term 3 sales launch | Marketing | Engagement metrics cited as growing (not quantified) | Ongoing |
| Nov 2025 | 100:1 consolidation | Capital structure | 4.67bn to about 46.7M shares | Completed |
| FY2026–27 | Pipeline: Neurodivergent Learning Strategies, Coaching, AI for Educators, 21-Day Reset, MHFA instructor certification | Product | MHFA instructor rollout Q4 CY2026 | In development |
| 23 Jul 2026 | Resilient Educator Partnership | Partnership / contract | At least 60 teachers initially, potential over 400 across over 250 schools; potential YCDI! revenue over AUD 0.5M by end-2027 | Launching Oct 2026 |
| 24 Aug 2026 | Datasphere acquisition and Technion option | M&A / technology bet | Qualifying financing USD 650k; further USD 1.0M and USD 1.35M conditions; 2% royalty | Completed about 29 Sep–1 Oct 2026; licence status unconfirmed |
| Aug–Sep 2026 | AUD 3.3M capital raising (placement AUD 2.8M plus SPP up to AUD 0.5M) with 1-for-3 AUD 0.15 five-year options | Capital | Use of funds disclosed (see below) | Completed; SPP about 4x oversubscribed |
| Use | AUD | % |
|---|---|---|
| Qualifying financing to Datasphere (USD 650k) | 920,000 | 27.9 |
| Datasphere due diligence, integration, commercialisation | 580,000 | 17.6 |
| Product development (existing business) | 650,000 | 19.7 |
| Product personnel (existing business) | 350,000 | 10.6 |
| Sales and marketing (existing business) | 200,000 | 6.1 |
| Working capital | 402,000 | 12.2 |
| Costs of raising | 198,000 | 6.0 |
| Total | 3,300,000 | 100.0 |
Use of funds, August 2026 raise (company statement of intent, AUD)
Guidance and targets
TALi provides no quantitative revenue, EBITDA or medium-term financial guidance. Qualitative guidance (FY26 Annual Report): YCDI! trading income was consistent with forecasts; operating cash burn was low and in line with guidance; refreshed 2026 programs and partnership offerings are expected to support YCDI! revenue growth in H2 CY2026. The only quantified forward figure is the Resilient Educator potential of over AUD 0.5M by end-2027. The YCDI! value-in-use model assumed 15% revenue growth, an internal planning assumption, not guidance. No ESG or sustainability commitments are disclosed. No formal cost-reduction program is announced beyond prudent cost management.
Products & Services
YCDI! (You Can Do It! Education) — current revenue engine
| Product / service | Description | Target customer | Launch / latest version | Pricing model | Source |
|---|---|---|---|---|---|
| YCDI! Early Years program | SEL curriculum for ages 3–5 built around the five "keys" (confidence, persistence, organisation, getting along, resilience); redesigned puppets | Early-childhood centres, kindergartens | Puppets redesigned 2025–26 | Subscription plus physical goods | FY26 Annual Report |
| YCDI! Primary and Secondary programs | Evidence-based SEL lessons for ages 5–18, ACARA-aligned | Schools | Migrated to CANVAS LMS, completed by Feb 2026 | Annual digital subscription, flexible tiers | FY26 Annual Report; 1HFY26 announcement |
| CANVAS-based digital platform | Video learning, embedded pre/post surveys, improved reporting, dedicated technical support and onboarding | Schools | Completed FY2026 | Included in subscription tiers | FY26 Annual Report |
| Bundle pathway quiz | Website tool that personalises product recommendations | School buyers | FY2026 | Free (sales tool) | FY26 Annual Report |
| "I am THRIVING" podcast | Podcast integrated into CANVAS for professional learning | Educators | FY2026 | Included | FY26 Annual Report |
| "YCDI Tuesday Thrive" | Weekly re-engagement campaign | Subscribers | FY2026 | Marketing | FY26 Annual Report |
| Puppet Activity Book and Take-Home Travel Bag | Physical resources for classroom and home | Early years, parents | FY2026 | Unit sale | FY26 Annual Report |
| Tertiary self-paced online courses | Professional and tertiary-level courses | Educators, students | Ongoing | Per course | FY26 Annual Report |
| Parent education micro-courses | Short courses for parents | Parents | Ongoing | Per course | FY26 Annual Report |
| Workshops and PD | Face-to-face/online professional development | Schools | Ongoing | Fee for service | TipRanks summary of Jan 2026 update |
| Resilient Educator Partnership | 14-month teacher wellbeing program: online courses, workshops, Mental Health First Aid International certification, ICF-accredited coaching, termly resilience assessments via The Resilience Institute Global | Teachers in an independent schools network (Victoria) | Launch Oct 2026, through end-2027 | Program fee; potential revenue to YCDI! over AUD 0.5M by end-2027 | Announcement, 23 Jul 2026 |
| Pipeline program | Description | Status |
|---|---|---|
| Neurodivergent Learning Strategies for All | SEL support for neurodivergent students; may incorporate ReadyAttentionGo! | In development |
| YCDI Coaching Program | Live sessions complementing digital content | In development |
| AI for Educators | Teacher skills for ethical AI use | In development |
| 21-Day Reset for Educators | Wellbeing and resilience program | In development |
| Mental Health First Aid instructor certification | Whole-school staff accreditation; certified instructor rollout planned Q4 CY2026 | Planned |
| Additional ReadyAttentionGo! module | Addresses attention difficulties | In development (TipRanks summary, Jan 2026) |
Legacy TALi digital-health products
| Product | Description | Target customer | Version / status | Pricing model | Source |
|---|---|---|---|---|---|
| TALi DETECT® | Game-based digital screening, about 20–30 minutes of cognitive tasks (described elsewhere as seven tests) that profile a child's attention against peers | Clinicians, schools, parents | US reimbursement pathway reported 2019; commercial activity dormant since Genius outsourcing; rights subject to administrator engagement from Mar 2025 | Historically per-assessment/licence; clinician screening payment cited at about USD 36 (2019) | Stoxray, Parqet, Stockhead (secondary) |
| TALi TRAIN® | Five-week, play-based cognitive training program (ages about 3–8) targeting selective attention and numeracy, designed with Monash University neuroscientists on about 20 years of research | Clinicians, NDIS participants, parents | Controlled commercial launch to 108 clinicians; dormant | Licence/subscription (historical) | Startup Daily; Dealroom (secondary) |
| TALi Portal | Dashboard for clinicians, educators and parents to monitor daily performance and tailor the program | Clinicians, educators, parents | Legacy | Bundled | Parqet (secondary) |
| ReadyAttentionGo! | Training modules on the TALi patented platform; now positioned as a component of YCDI! neurodivergent strategies | Schools via YCDI! | Being re-purposed 2026 | To be determined | FY26 Annual Report |
Datasphere / Technion technology (pre-commercial)
| Asset | Description | Status | Economic terms | Source |
|---|---|---|---|---|
| Option over "In-memory Computing in Emerging Memory Technologies" IP and TRDF know-how | Memristive logic and memristive Memory Processing Unit (mMPU) architecture developed by Prof. Shahar Kvatinsky's group at Technion. Performs analytics inside memory rather than shuttling data to a processor. | Option to negotiate exclusive licence until 3 Oct 2026, exercisable on USD 650k qualifying financing. No licence granted as at the 24 Aug 2026 announcement. Exercise/licence status after 3 Oct 2026 was not confirmed in sources reviewed. | 2% royalty on net sales; 20% of sublicence fees; reimburse NIS 579,177 past patent costs (15%/40%/45% over 24 months); raise further USD 1.0M within 18 months and USD 1.35M within 36 months; TRDF to receive 30% of consideration (6.6M TALi shares) and board seat while at or above 3.5% | Datasphere announcement; Notice of Meeting |
The company stresses the technology is early-stage, unproven at commercial scale and generates no revenue.
Financial Narrative
Data-quality note
FY2024–FY2026 income statement, balance sheet and cash flow figures are taken from the audited FY2025 and FY2026 annual reports. FY2022–FY2023 figures are partly from the five-year summaries in those reports (net loss, share price, EPS) and partly from aggregators (TipRanks, Stoxray), marked as such. FY2025 figures were restated in the FY2026 report following finalisation of YCDI! purchase-price accounting: goodwill was reallocated to customer relationships and software, and a deferred tax liability was recognised. Both original and restated values are shown where they differ.
Income statement
Notes:
-
FY2022–FY2023 operating revenue, D&A, EBITDA, EBIT and pre-tax loss are aggregator (TipRanks) and unreconciled.
-
FY2024 operating revenue is net of AUD 30,343 refunds.
-
FY2024–FY2026 EBITDA is an analyst calculation: pre-tax loss plus D&A less interest income. FY2024 interest was AUD 85,493, FY2025 AUD 54,743, FY2026 AUD 12,274.
-
FY2024 EBIT is an analyst calculation: pre-tax loss less interest income (85,493) and other income (174,575, including grants, R&D incentive release and investment sale).
-
FY2025 values are restated per the FY2026 report. Originally reported FY2025: net loss AUD -656,885; pre-tax AUD -656,885; tax nil.
Per-share data
Notes:
-
FY2026 EPS is post-consolidation as reported.
-
FY2022–FY2024 post-consolidation EPS and share counts are analyst calculations (pre-consolidation figures multiplied by 100 for EPS, divided by 100 for shares). FY2022–FY2023 weighted shares are aggregator.
-
FY2025 is restated in the FY26 report.
-
No dividend has been paid since incorporation (FY26 Annual Report).
Margins and growth
Analyst calculations. FY2024 margins are not meaningful (negative revenue) and are shown as 0. FY2025 margins are mathematically extreme because of AUD 1,186 of revenue. Revenue CAGR FY2022–FY2026 (13,165 to 274,898) is about 114% per year (analyst calculation), but this reflects a change of business through acquisition rather than organic growth and should not be extrapolated.
Balance sheet
Notes:
-
FY2023 cash is the FY2024 opening balance. FY2023 intangibles are the FY2024 opening carrying amount. FY2023 deferred income is the FY2024 opening balance. FY2023 borrowings are inferred from AUD 503,744 repaid in FY2024. FY2023 equity is the FY2024 opening balance.
-
FY2025 is restated per the FY2026 report. Originally reported FY2025: goodwill AUD 1,307,964; total assets AUD 2,658,421; total liabilities AUD 386,894; equity AUD 2,271,527.
-
FY2022 balance-sheet detail is not publicly disclosed in sources reviewed.
-
Debt split (short/long): no borrowings at 30 June 2024, 2025 or 2026. Deferred consideration payable to The Bernard Group was AUD 120,000 current at 30 June 2026 (FY2025: AUD 80,000 current plus AUD 113,424 non-current).
-
Issued capital AUD 216,081,773 against accumulated losses AUD 215,777,336 (FY2026) illustrates the scale of historic capital consumption.
-
Unused tax losses about AUD 168M, unrecognised (FY2026).
Cash flow
FY2022–FY2023 operating cash flow is aggregator (Stoxray). Capex is shown as nil where none is reported in FY2024–FY2026; for FY2022–FY2023 it is not disclosed in sources reviewed (no PP&E capex visible). FY2024 operating cash flow was flattered by a one-off AUD 666,813 R&D tax incentive receipt; underlying FY2024 burn was about AUD 1.03M (analyst calculation).
Ratios
Analyst calculations on average equity and average total assets (FY2025 restated). ROIC, net debt/EBITDA and interest coverage are not meaningful: EBITDA is negative, there is no debt and no interest expense. Cash conversion cycle is not meaningful given negligible receivables and inventory and subscription billing in advance. FY2026 receivables days are about 60 and inventory days about 300 on cost of sales (analyst calculations, low reliability at this scale).
Half-year data points
Source: 1HFY25 and 1HFY26 Appendix 4D (via TipRanks/InvestSMART summaries). The 1HFY25 "revenue" figure includes interest and other income.
Commentary on trends, inflections and drivers
Three regimes. FY2022 was the high-water mark of spend on the TALi platform (net loss AUD 6.9M, operating cash burn AUD 4.3M), funded by the 2019–2022 equity raisings. FY2023–FY2024 marked retrenchment. The August 2023 decision to outsource development, sales and support to Genius collapsed the cost base, refunded customers and triggered the FY2024 write-off of all TALi intangibles (AUD 4.19M, partly offset by a AUD 2.05M release of deferred grant/R&D income). FY2025 was a shell-like year: revenue AUD 1,186, cash burn of about AUD 0.1M a quarter, ending with the YCDI! acquisition.
FY2026 inflection. The first full year of YCDI! moved receipts from customers from nil to AUD 437,556 and recognised revenue to AUD 274,898, with an 83% gross margin. But operating costs rose too: personnel AUD 452k (from 197k), amortisation of acquired intangibles AUD 157k, professional fees AUD 346k, insurance AUD 84k. Underlying EBITDA (ex-impairment) was about AUD -0.95M versus AUD -0.71M in FY2025. The headline AUD 2.21M loss was dominated by the AUD 1.34M impairment that wrote the whole YCDI! cash-generating unit to nil roughly 12 months after purchase.
Cash runway was the binding constraint until September 2026. Cash fell from AUD 2.99M (FY2023) to AUD 0.97M (FY2026). The going-concern note relied on the AUD 3.3M raise. The SPP's heavy oversubscription (about AUD 2.0M applied against AUD 0.5M) and completion of the AUD 2.8M placement mean pro-forma cash is likely about AUD 3.5–4.0M before the AUD 0.92M qualifying-financing payment to Datasphere. That estimate assumes about AUD 3.3M gross less 6% costs plus about AUD 0.9M of opening cash net of Q1 FY2027 burn; it is an analyst estimate pending the September-quarter Appendix 4C. On FY2026 burn rates (operating about AUD 0.74M per year) that is a multi-year runway for YCDI! alone. But the Datasphere/Technion conditions (USD 1.0M within 18 months and USD 1.35M within 36 months of the licence) imply further capital needs if the licence is executed.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Ownership | Function | Since |
|---|---|---|---|
TALi Digital Limited | Listed parent | Holding company, corporate, listing | 2004 |
TALi Health Pty Ltd | 100% | Holds TALi DETECT/TRAIN/ReadyAttentionGo! IP and legacy operations | — |
YCDI Education Australia Pty Ltd | 100% | Operates YCDI! SEL business | 12 Jun 2025 |
Datasphere Analytics Pty Ltd (ACN 689 577 419) | 100% | Holds Technion option/MOU over memristive in-memory computing IP | Completion about 29 Sep–1 Oct 2026 |
Business Lines
| Business line (AUD) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Legacy TALi revenue net of refunds | -28,347 | 0 | 0 |
YCDI! revenue | 0 | 1,186 | 274,898 |
Total operating revenue | -28,347 | 1,186 | 274,898 |
Revenue type (AUD)
| Revenue type (AUD) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Service revenue recognised over time | 1,996 | 0 | 194,094 |
Refunds | -30,343 | 0 | 0 |
Sale of goods | 0 | 1,186 | 38,986 |
Royalties | 0 | 0 | 41,818 |
Total operating revenue | -28,347 | 1,186 | 274,898 |
Income Statement (AUD)
| Metric (AUD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating revenue | 13,165 | 26,627 | -28,347 | 1,186 | 274,898 |
Revenue and other income incl. interest | — | — | 231,721 | 55,591 | 286,744 |
Cost of sales | — | — | 0 | 0 | -46,738 |
Gross profit | — | — | -28,347 | 1,186 | 228,160 |
Net impairment | — | — | -2,144,102 | 0 | -1,335,237 |
Depreciation and amortisation | -371,380 | -319,750 | -178,198 | -5,155 | -156,802 |
EBITDA (reported basis) | -7,170,000 | -2,540,000 | -3,024,336 | -711,628 | -2,281,199 |
EBITDA excluding impairment | — | — | -880,234 | -711,628 | -945,962 |
Operating income (EBIT, excl. interest) | -7,720,000 | -3,030,000 | -3,202,534 | -716,445 | -2,437,573 |
Pre-tax loss | -7,550,000 | -2,860,000 | -3,117,041 | -662,040 | -2,425,727 |
Income tax benefit | — | — | 0 | 1,416 | 214,068 |
Net loss | -6,936,129 | -2,258,623 | -3,117,041 | -660,624 | -2,211,659 |
Per-Share Data and Share Count (millions)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Basic EPS, as originally reported (AUD cents, pre-consolidation) | -0.69 | -0.11 | -0.09 | -0.02 | -4.83 |
Basic EPS, post-consolidation basis (AUD cents) | -69 | -11 | -9.46 | -2.00 | -4.83 |
Diluted EPS (AUD cents, post-consolidation basis) | -69 | -11 | -9.46 | -2.00 | -4.83 |
Dividends per share (AUD cents) | 0 | 0 | 0 | 0 | 0 |
Weighted average shares, post-consolidation basis (millions) | 12.0 | 21.5 | 32.95 | 33.10 | 45.78 |
Margin Analysis (%)
| Metric (%) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Gross margin | 0 | 100.0 | 83.0 |
EBITDA margin excluding impairment | 0 | -60,002 | -344.1 |
Net margin | 0 | -55,702 | -804.5 |
Revenue growth YoY | 0 | 0 | 23,079 |
Balance Sheet (AUD)
| Metric (AUD) | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Cash and cash equivalents | 2,986,733 | 2,122,383 | 1,291,599 | 973,791 |
Trade and other receivables | — | 64,541 | 28,943 | 44,869 |
Inventories | 0 | 0 | 51,713 | 38,375 |
Total current assets | — | 2,191,882 | 1,376,710 | 1,081,297 |
Goodwill | 0 | 0 | 635,260 | 0 |
Other intangibles | 4,358,389 | 0 | 856,779 | 0 |
Total assets | — | 2,191,882 | 2,868,749 | 1,081,297 |
Trade and other payables (current) | — | 41,606 | 269,937 | 246,435 |
Deferred income | 2,136,252 | 0 | 3,532 | 189,499 |
Total liabilities | — | 41,606 | 600,961 | 435,934 |
Total debt (borrowings) | 503,744 | 0 | 0 | 0 |
Net debt (net cash shown negative) | -2,482,989 | -2,122,383 | -1,291,599 | -973,791 |
Total equity | 5,168,546 | 2,150,276 | 2,267,788 | 645,363 |
Working capital | — | 2,150,276 | 1,103,241 | 645,363 |
Cash Flow (AUD)
| Metric (AUD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Receipts from customers | — | — | -31,181 | 0 | 437,556 |
R&D tax incentive received | — | — | 666,813 | 0 | 0 |
Operating cash flow | -4,328,145 | -2,000,141 | -363,349 | -472,806 | -737,321 |
Capex | 0 | 0 | 0 | 0 | 0 |
Free cash flow | -4,328,145 | -2,000,141 | -363,349 | -472,806 | -737,321 |
Business acquisitions | 0 | 0 | 0 | -1,140,000 | -80,000 |
Proceeds from share issues | — | — | 0 | 800,000 | 577,525 |
Share issue costs | — | — | 0 | -53,000 | -77,919 |
Repayment of borrowings | — | — | -503,744 | 0 | 0 |
Dividends paid | 0 | 0 | 0 | 0 | 0 |
Buybacks | 0 | 0 | 0 | 0 | 0 |
Net change in cash | — | — | -867,093 | -830,806 | -317,715 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
ROE (%) | -85.2 | -29.9 | -151.8 |
ROA (%) | — | -26.1 | -112.0 |
Current ratio (x) | 52.7 | 5.03 | 2.48 |
Debt to equity (x) | 0 | 0 | 0 |
Asset turnover (x) | — | 0.0005 | 0.14 |
Income Statement (AUD) (1HFY2025–1HFY2026)
| Metric (AUD) | 1HFY2025 | 1HFY2026 |
|---|---|---|
Revenue (as reported in Appendix 4D) | 36,704 | 72,834 |
Loss after tax | -263,945 | -570,848 |
Region (AUD) Overview
| Region (AUD) | Services | Goods | Royalties | Total |
|---|---|---|---|---|
Australia | 172,454 | 20,167 | 37,181 | 229,802 |
New Zealand | 17,398 | 160 | 0 | 17,558 |
Europe | 0 | 16,604 | 4,637 | 21,241 |
Rest of World | 4,242 | 2,055 | 0 | 6,297 |
Total | 194,094 | 38,986 | 41,818 | 274,898 |
Region (AUD) Overview (Annual)
| Region (AUD) | FY2026 |
|---|---|
Australia | 229,802 |
New Zealand | 17,558 |
Europe | 21,241 |
Rest of World | 6,297 |
Per-Share Data
| Metric (AUD per share) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
FY-end price, as reported (pre-consolidation basis to FY2025) | 0.032 | 0.006 | 0.002 | 0.002 | 0.001 | 0.063 |
FY-end price, post-consolidation equivalent | 3.20 | 0.60 | 0.20 | 0.20 | 0.10 | 0.063 |
Change by Horizon
| Horizon (to 30 Jun 2026) | Change |
|---|---|
1-year (from AUD 0.10) | -37% |
3-year (from AUD 0.20) | -69% |
5-year (from AUD 3.20) | -98% |
Market Index 1-year relative to ASX 200 (snapshot date unclear) | -41.42% |
Valuation Multiples
| Multiple | TALi (analyst calculation) | Comment |
|---|---|---|
Market cap | AUD 10.8M–13.5M | At AUD 0.08–0.10 on about 134.7M shares |
Enterprise value | About AUD 7–10M | Assuming about AUD 3.5–4.0M pro-forma cash and no debt (estimate) |
EV / Sales (FY2026) | About 25–36x | Not comparable to profitable edtech |
P / B | About 15–20x on FY2026 book of AUD 0.65M | Book materially higher post-raise; recalc after Dec-26 half |
Securities on Issue
| Security | Number | Terms | Source |
|---|---|---|---|
Quoted ordinary shares | 112,727,470 | — | Appendix 2A, 1 Oct 2026 |
Consideration shares (Datasphere) | 22,000,000 | Issued 1 Oct 2026 (6.6M to TRDF) | Appendix 2A, 1 Oct 2026 |
Unquoted options (TD1AI) | 21,533,258 | AUD 0.15, expire 29 Sep 2031 | Appendix 2A, 1 Oct 2026 |
Unquoted options (FinCap) | 1,250,000 | AUD 0.10, expire Nov 2028 | FY26 AR; Appendix 2A |
Other unquoted options | 1,210,516 | Various (AUD 0.40–1.20; 2027–2028) | Appendix 2A, 1 Oct 2026 |
Share Price & Returns
| Date | Raise | Price | Amount (AUD) | Source |
|---|---|---|---|---|
Jul 2017 | Placement plus rights issue (Newly) | — | — | BioSpectrum Asia |
Jul 2018 | Placement | — | 2.7M | Biotech Daily |
25 Nov 2019 | Placement | — | 6.2M | InvestSMART |
Mar 2022 | Capital raise (broker options) | — | — | FY25 AR note 18 |
Mar 2023 | Capital raise (85M broker options) | — | — | FY25 AR note 18 |
19 Jun 2025 | Placement (800M shares) | 0.001 | 800,000 | FY25 AR |
Jul 2025 | Entitlement offer (1-for-6) | 0.001 | About 131,388 | FY25 AR |
Sep–Oct 2025 | Shortfall placement | 0.001 | About 446,000 | FY26 AR (total FY26 issues AUD 577,525) |
Aug–Oct 2026 | Placement (56M) plus SPP (up to 10M) with 1-for-3 options | 0.05 | About 3.3M | Datasphere announcement; Appendix 2A |
Analyst Conclusions
Management guidance
No numerical guidance. Management expects the refreshed 2026 program suite, flexible subscriptions and partnership offerings to support YCDI! revenue growth in H2 CY2026. It describes the YCDI! business as well-positioned for sustainable growth, and says it continues to assess assets to bolster the platform (FY26 Annual Report). Resilient Educator potential of over AUD 0.5M by end-2027 is the only quantified forward indicator.
Consensus
None. No analyst coverage.
Bull case
-
The education core is inflecting from a near-zero base. FY2026 receipts of AUD 437,556 and deferred income of AUD 189,499 show billings running well ahead of recognised revenue (AUD 274,898). Adding Resilient Educator (over AUD 0.5M potential to end-2027) and the MHFA certification rollout could plausibly double revenue within two years, at an 83% gross margin.
-
The balance sheet has been reset. About AUD 3.3M was raised against FY2026 operating burn of AUD 0.74M. Retail demand was strong (SPP about 4x covered), and there is no debt. TALi can fund YCDI! growth and the first Datasphere phase without immediate further dilution. The AUD 0.15 options could add about AUD 3.2M if the share price performs.
-
The Technion option is cheap asymmetric exposure. For 22M shares (AUD 1.1M deemed) plus USD 650k of qualifying financing, TALi gains a pathway to an exclusive, worldwide, sublicensable licence over a recognised academic group's processing-in-memory IP, at a modest 2% royalty and 20% of sublicence fees. A single sublicensing deal with a memory or AI-hardware player could be worth multiples of the current market capitalisation.
Bear case
-
Management's own numbers say YCDI! is worth little. The CGU was impaired to nil 12 months after purchase, on a value-in-use model that already assumed 15% revenue growth. Personnel, insurance, professional and KMP costs far exceed gross profit (AUD 228k). Listed-company overheads alone may absorb any growth.
-
Datasphere is a pre-licence, capital-hungry science project. The option expired 3 October 2026 unless exercised. The licence carries USD 2.35M of additional raising conditions within 36 months plus patent-cost reimbursements, and the technology is explicitly unproven at commercial scale. The strategic link to a school SEL business (sovereign student-data analytics) is thin. Execution requires semiconductor expertise the board does not obviously possess.
-
History and structure argue for caution. The entity has consumed AUD 216M of paid-in capital across three strategies (HIV drug, paediatric digital health, now SEL plus deep tech) with no sustained commercial success. Share-price performance was -98% over five years on a consolidated basis. Governance is thin (three directors, no CEO or CFO, an executive chair labelled independent). About 24M options sit over the register.
Catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable | What to watch |
|---|---|---|
| By 31 Oct 2026 | September-quarter Appendix 4C | Post-raise cash; USD 650k Datasphere payment; customer receipts |
| Oct 2026 onward | Technion option exercise and licence negotiation | Confirmation of exercise before 3 Oct expiry; 45-day negotiation; definitive licence signing (must occur within 180 days of exercise) |
| Oct 2026 | Resilient Educator launch | Teacher sign-ups against the 60 minimum and 400 potential |
| 26 Nov 2026 | AGM | Remuneration report vote; director elections; any TRDF board nominee |
| Q4 CY2026 | MHFA instructor certification rollout | Whole-school accreditation uptake |
| Jan 2027 | December-quarter 4C | Term 1 2027 pre-sales; deferred income |
| Feb 2027 | 1HFY27 Appendix 4D | Revenue growth vs 1HFY26 (AUD 72.8k); Datasphere accounting (intangible or expense) |
| 2,027 | Datasphere technical roadmap | Prototype milestones; sublicensing discussions; USD 1.0M funding within 18 months of licence |
| Ongoing | Further AI M&A | Additional acquisitions and dilution |
| Ongoing | Genius / Vertical 4 rights recovery | Whether TALi DETECT/TRAIN rights are recovered and re-commercialised via YCDI! |
Analyst verdict
TALi Digital is best understood not as a digital-health company but as a recapitalised listed shell. It contains two assets of very different character: a small, genuine, high-gross-margin school SEL franchise (YCDI!) and a speculative option on Technion processing-in-memory IP (Datasphere).
The audited record is unflattering. FY2026 revenue of AUD 274,898 against a AUD 2.21M loss. A full impairment of the AUD 1.34M YCDI! acquisition within a year. Rising operating cash burn. AUD 216M of historic capital consumed across three failed or abandoned strategies. The only consistently positive operating datapoints are the 83% gross margin, the build in deferred income and the Resilient Educator contract. All are real, but small.
The August–October 2026 transactions change the risk profile more than the fundamentals. The company now has about AUD 3.3M of fresh gross capital, a refreshed board with capital-markets and digital-asset backgrounds, and a narrative (AI-assisted, sovereign-data education platform) that the market has rewarded: shares trade above the AUD 0.05 raise price, implying an estimated AUD 11–13M market capitalisation. Most of that value must be attributed to the Datasphere option and the cash. Management's own value-in-use test priced YCDI! below AUD 1.1M.
The decisive near-term question is binary and verifiable: did Datasphere exercise the Technion option before 3 October 2026, and will a definitive licence follow within the MOU timelines? Without the licence, TALi reverts to a sub-scale SEL operator whose overheads exceed its gross profit. With it, TALi becomes a long-dated deep-technology venture that will need USD 2.35M or more of further funding and specialist execution well outside its demonstrated competence.
On the evidence available, TALi is a high-risk, event-driven speculation. Monitor the September-quarter 4C, any licence announcement, and YCDI! revenue in 1HFY27 before forming a fundamental view. No rating or price target is offered.
APPENDIX A — Source reliability key
| Tier | Sources | Treatment |
|---|---|---|
| Tier 1 (audited / primary) | FY2025 and FY2026 Annual Reports and Appendix 4E; 1H Appendix 4D; ASX announcements (Datasphere, Notice of Meeting, AGM date); ASX Notice 0021.20.12 | Relied upon |
| Tier 2 (summaries of primary filings) | Kalkine, InvestSMART, TipRanks, Stockwire X, Sharecafe and FNN summaries of Appendix 2A/3G, EGM results, 4C, SPP | Used for facts not otherwise retrieved; flagged |
| Tier 3 (aggregator / historical media) | TipRanks financials, Stoxray, Simply Wall St, Morningstar, Market Index register, MarketBeat, Dealroom, Biotech Daily, Startup Daily, Stockhead, Motley Fool, SmallCaps | FY2022–FY2023 data and pre-2019 history; flagged as unreconciled |
APPENDIX B — Discrepancies noted
| Item | Source A | Source B | Treatment |
|---|---|---|---|
| FY2025 net loss | AUD -656,885 (FY25 Annual Report, original) | AUD -660,624 (FY26 Annual Report, restated) | Restated used in tables; original noted |
| FY2025 goodwill | AUD 1,307,964 provisional (FY25 AR) | AUD 635,260 goodwill plus AUD 856,779 other intangibles (FY26 AR restated) | Restated used |
| FY2025 total assets | AUD 2,658,421 (FY25 AR) | AUD 2,868,749 (FY26 AR restated) | Restated used |
| FY2026 revenue headline | AUD 286,744 "revenues from ordinary activities and other income" (Appendix 4E) | AUD 274,898 operating revenue (P&L note 4) | Both shown; operating revenue used for margins |
| FY2024 revenue | AUD 1,996 (TipRanks, gross service revenue) | AUD -28,347 net of refunds (FY25 AR) | Audited net figure used; gross noted |
| Employees | 13 (Morningstar) | Not disclosed in filings; YCDI! deal included no employees | — |
| Market cap | AUD 2.1M (Simply Wall St), AUD 3–4M (InvestSMART), €2.26M (Parqet) | About AUD 10.8–13.5M (analyst calculation, post-Oct 2026 share count) | Aggregators pre-date recapitalisation; analyst estimate used |
| Headquarters suburb | Camberwell (Morningstar, MarketBeat) | Hawthorn East (FY26 AR, Simply Wall St) | FY26 AR used (current) |
| SPP outcome | About AUD 2.0M applications (Stockwire X) | Quoted share count implies about 10M SPP shares (AUD 0.5M) issued | Scale-back inferred, unconfirmed |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Prior roles / experience | Education |
|---|---|---|---|---|
Dr David Brookes | Executive Chair (from 24 Mar 2026); previously NED from 29 Jun 2020 and Audit chair to 18 Oct 2022; member of Audit and Remuneration & Nomination committees | 29 Jun 2020 | Executive Chairman, Anatara Therapeutics (ASX: ANR). Former Chair of RHS Ltd (sold to PerkinElmer, Jun 2018). Former NE Chair, Invert Graphite (ASX: IVG); former NED, Island Pharmaceuticals (ASX: ILA). | MBBS (Adelaide), FACRRM, FAICD |
Will Hamilton | Independent NED; Chair of Remuneration & Nomination Committee | 24 Mar 2026 | Chief Commercial Officer and GM, DigitalX Limited. Former senior roles at Animoca Brands and Trovio Group (digital asset investment). M&A/advisory at Washington H. Soul Pattinson and Ernst & Young. About 14 years' experience. | Master of Business (Finance), BSc |
George Rolleston | Independent NED; Chair of Audit & Risk Committee; member of Remuneration & Nomination | 16 Jun 2026 | Founder and MD, Asset Growth Fund Pty Ltd and Suubee Group Pty Ltd. NED, Felix Group Holdings (ASX: FLX). Former director, MHM Automation (NZX: MHM), Feb 2019–Mar 2024. | MAPPF, B.Bus (Law) |
Tim Luscombe | Company Secretary (outsourced CFO function via Bio101) | 5 Dec 2022 | Director of Bio101; CFO/Company Secretary for multiple ASX and private healthcare companies | BCom (Melbourne), CA, GIA(Cert) |
Mark Simari | Executive Chair | NE Chair from 6 Oct 2022; Executive Chair from 16 Aug 2023; earlier director 2016–2020 | Resigned 24 Mar 2026 | Co-founder and former MD of Paragon Care (2008–2018); directorships at Careteq, IDT Australia, Opyl, Xpon (per FY25 report). Departure coincided with the AI-focused M&A pivot and board refresh. |
Stephen Munday | Independent NED, Audit & Risk chair | 18 Oct 2022 – 16 Jun 2026 | Resigned 16 Jun 2026 | CA, FGIA, FCG, GAICD, MBA; Careteq director. Replaced by Rolleston. |
David Williams | NED | to 29 Feb 2024 | Resigned | — |
Dr MB Brinson | KMP (consultant) | to 11 Sep 2023 | Consulting ended | Paid AUD 63,899 in FY2024 |
Glenn Smith | CEO (Novita era) | c.2017–2019+ | — | Healthcare/recruitment background (Biotech Daily, 2018) |
Directors' Remuneration
| Director | Base fees | Bonus | Super | Share-based | Total |
|---|---|---|---|---|---|
Dr D Brookes | 56,141 | 0 | 6,737 | 2,726 | 65,604 |
W Hamilton (from 24 Mar 2026) | 14,095 | 0 | 0 | 0 | 14,095 |
G Rolleston (from 16 Jun 2026) | 1,953 | 0 | 234 | 0 | 2,187 |
M Simari (to 24 Mar 2026) | 67,500 | 0 | 0 | 5,177 | 72,677 |
S Munday (to 16 Jun 2026) | 50,313 | 0 | 0 | 2,726 | 53,039 |
Total | 190,002 | 0 | 6,971 | 10,629 | 207,602 |
Directors' Remuneration (Annual)
| Metric (AUD) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Total KMP compensation | 392,670 | 226,136 | 207,602 |
Share-based payments to KMP | 98,771 | 31,136 | 10,629 |
Major Shareholders
| Holder | Shares (pre-consolidation) | % (then) |
|---|---|---|
Finexia Wealth Pty Ltd (Client Nominee A/C) | 477,304,487 | 11.29 |
Asset Growth Fund Pty Ltd (Rolleston-associated) | 201,644,091 | 4.77 |
Sailors of Samui Pty Ltd | 159,817,044 | 3.78 |
Keiser Investments Pty Ltd (Gann Family Retirement A/C) | 100,000,000 | 2.37 |
Octifil Pty Ltd | 98,870,192 | 2.34 |
Bluewater Asset Management Pty Ltd (Teefish Super Fund A/C) | 83,134,580 | 1.97 |
Charkaroo Pty Ltd (Charmarbelle A/C) | 77,909,092 | 1.84 |
GP Securities Pty Ltd | 72,571,430 | 1.72 |
BNP Paribas Nominees (IB AU Noms Retailclient) | 70,518,860 | 1.67 |
Calama Holdings Pty Ltd (Mambat Super Fund A/C) | 67,500,000 | 1.60 |
Competitive Landscape
Key Competitors
| Competitor | Type | Market | Relative positioning vs YCDI! |
|---|---|---|---|
Smiling Mind | Australian not-for-profit; free mindfulness/SEL app and school programs | Australia | Free offer pressures pricing |
The Resilience Project | Australian private provider of wellbeing programs and curriculum | Australia | Strong brand in Victorian schools; direct overlap |
Berry Street Education Model | Not-for-profit trauma-informed PD and education model | Australia | Overlaps on PD and teacher wellbeing |
Positive Education programs (e.g., Institute of Positive Education) | School-based providers | Australia | Overlap in independent schools |
Second Step (Committee for Children) | US non-profit, global SEL curriculum | Global | Larger evidence base and scale |
Zones of Regulation | Commercial curriculum | Global | Strong in neurodivergent/self-regulation niche |
Panorama Education | US SEL survey/data platform | US | Data/analytics differentiation, which TALi now targets |
Everyday Speech / Move This World | US digital SEL video curricula | US | Digital-first competitors |
Kimochis and similar early-years SEL tools | Product-led early years | Global | Compete with YCDI! puppets and early-years kits |
Key Competitors by Competitor Class
| Competitor class | Examples (publicly known) | Notes |
|---|---|---|
Memory majors with PIM programs | Samsung (HBM-PIM), SK hynix (AiM) | Vastly larger R&D budgets; commercial samples |
Analog/in-memory AI chip start-ups | e.g., Mythic, EnCharge AI, d-Matrix | Venture-funded, pre- or early-revenue |
ASX-listed neuromorphic peer | BrainChip Holdings (ASX: BRN) | Listed comparison point for investor narrative; different architecture |
Competitor Detail
| Metric | TALi Digital (FY2026) |
|---|---|
Revenue | AUD 0.27M |
Revenue growth | n.m. (acquisition-driven) |
Gross margin | 83.0% |
EBITDA margin (underlying) | -344% |



